News  
Simcere's Montmorillonite (Biqi) passed Quality Consistency Evaluation for Generic Drugs
Time:July10,2018


According to the database of the State Food and Drug Administration, "Biqi®-Montmorillonite Powder"  manufactured by Simcere Pharmaceutical (Hainan) Co., Ltd. is among the first batch of montmorillonite powder products to have passed the SFDA's Quality Consistency Evaluation for Generic Drugs.


Biqi® is a Class I OTC drug  for diarrhea. Biqi® APIs and preparations have passed the EU GMP certification, and are also included in the national health insurance catalogue since 2004.


© Copyright 2016 www.simcere.com All Rights Reserved.